FIELD: medicine, ophthalmology.
SUBSTANCE: one should carry out antiglaucomatous operation; on finishing the main stages of surgical interference before sealing a conjunctival incision it is necessary to apply a subconjunctival catheter (SCC) under a conjunctival fragment and Tenon's membrane. Catheter is made of biologically inert soft polymeric material as a tube with one bevelled end. One should apply this catheter at distal third of surface scleral fragment (SSF) being subconjunctivally and under Tenon's membrane. Internal bevelled end of SCC should be placed in the center of distal third of SSF in order this slope should be directed towards underlying tissue. Its external end should b withdrawn subconjunctivally being beyond the limits of operation so that it should protrude beyond the limits of conjunctival fragment for about 5-6 mm. Operation should be finished. During 2-4 wk through a SSF it is necessary to introduce antiphlogistic and antiproliferative preparations by entering the lumen of external SCC end through its covering conjunctiva. On finishing a course of therapy one should remove SCC through a little conjunctival incision under external end of a catheter. Application of the present method is directed to decrease ocular inflammatory reaction as a result of surgical operation and simplified development of filtration pad. The innovation provides unimpeded outflow of intra-ocular liquid and stable normalization of intra-ocular pressure in post-operational period.
EFFECT: higher efficiency of stabilization.
1 cl, 2 ex
Authors
Dates
2006-08-10—Published
2004-11-11—Filed